Tezspire Approved in EU for Severe Nasal Polyps
Update: 2025-10-22
Description
EU Approves Tezspire: A Game-Changer for Severe Sinusitis Sufferers! AstraZeneca and Amgen's new add-on therapy offers hope for adults with chronic rhinosinusitis with nasal polyps (CRSwNP) who haven't found relief with standard treatments. Clinical trials showed Tezspire significantly reduced nasal polyps and congestion, decreasing the need for surgeries and corticosteroids. Is this the breakthrough CRSwNP patients have been waiting for?
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
